Acute Dystonia Management in Patients Treated with High‑Potency Antipsychotics

Immediate Pharmacologic Treatment

High‑Risk Patient Identification

Prevention Strategies

Discontinuation of Prophylactic Anticholinergics

Administration Route Considerations

Acute Dystonia: Evidence‑Based Management and Prevention

Life‑Threatening Presentations

• Laryngeal dystonia is a medical emergency that manifests with choking sensation, breathing difficulty, or stridor and requires immediate anticholinergic therapy to avoid respiratory compromise and fatal outcomes. 4

Preferred Route for Parenteral Antipsychotic Administration

• In emergency settings, intramuscular injection is recommended over intravenous administration for parenteral antipsychotic delivery. 4

Assessment of Prophylactic Anticholinergic Use

• After the acute treatment phase or when the antipsychotic dose is reduced, clinicians should reassess the necessity of prophylactic anticholinergic agents, as many patients no longer require them during long‑term maintenance therapy. 5

Differential Diagnosis and Treatment Selection

• Acute dystonia must be distinguished from akathisia and drug‑induced parkinsonism; anticholinergic agents are not consistently effective for akathisia, which responds better to lipophilic beta‑blockers such as propranolol. 5

Evidence‑Based Recommendations for Anticholinergic Use in Acute Dystonia

Pediatric Dosing Guidelines

• In children, the anticholinergic agents benztropine and diphenhydramine are employed for acute dystonia; dosing should be calculated on a weight‑based basis and adjusted to the minimal effective amount. 6

Contraindications in Tardive Dyskinesia

• Anticholinergic medications are not recommended for the treatment of tardive dyskinesia because they do not alleviate symptoms and may obscure the clinical picture. 6